Live Attenuated Influenza Vaccine as a Nasal Model for Influenza Infection
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to develop a nasal model for influenza infection using the live
attenuated influenza vaccine (LAIV). The investigators will administer LAIV to healthy adult
volunteers in order to simulate influenza infection, and obtain nasal specimens to measure
influenza virus and inflammatory/immune responses.